Ally Bridge Group (NY) LLC

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
18
Total value ($000)
$76,049
Net value change ($000)
-37,022 (-32.7%)
New positions
4
Sold out positions
13
Turnover %
119.8%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AMLX 5,296 NEW
STTK 4,264 NEW
OBSIDIAN THERAPEUTICS INC 4,153 NEW
EWTX 4,144 122.5%
VOGENX INC 745 NEW
EPRX 436 26.2%
ANTX 253 9.9%
Top Reduces (Value $000, Stocks/ETFs)
NERV -6,530 -54.1%
FIRST TRACKS BIOTHERAPEUTICS -5,720 -100.0%
AXSM -4,037 -100.0%
WHWK -3,746 -100.0%
ASMB -3,417 -88.8%
CLYM -3,249 -100.0%
KURA -3,181 -100.0%
CTMX -2,906 -100.0%
PALI -2,569 -100.0%
SLDB -2,557 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 32,638 (42.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type